Risk Factors and Severity of Neonatal Hyperbilirubinemia among Admitted Neonates in Swat, Khyber Pakhtunkhwa, Pakistan
Abstract
Objective: To determine the incidence and levels of total, direct, and indirect serum bilirubin, and to identify the clinical and demographic determinants of neonatal hyperbilirubinemia among jaundiced neonates admitted to a tertiary care hospital in district Swat, Khyber Pakhtunkhwa, Pakistan.
Methodology: This descriptive cross-sectional study was conducted in the NICU of Saidu Group of Teaching Hospitals, Swat, over six months, enrolling 160 neonates with jaundice. Neonates without jaundice and those not admitted at SGTH were excluded. Data on sociodemographic and clinical variables, along with serum bilirubin levels, were collected via a structured questionnaire. Analysis was performed using SPSS version 22, summarizing categorical variables as frequencies and percentages, with associations tested using the chi-square test (p<0.05 significant).
Results: Of 160 neonates studied, 25% were preterm, 75% term, and 59.4% male. High total bilirubin levels (13–18 mg/dL) were found in 50.6%, with severe cases (>18 mg/dL) at 27.5%. Direct bilirubin was moderately elevated in 53.1%, while 52.5% had severely raised indirect bilirubin (>13 mg/dL). Significant associations with total bilirubin included age at admission and mode of delivery (p<0.001), as well as breastfeeding (p=0.006 for total and p=0.029 for indirect bilirubin). Key determinants of hyperbilirubinemia included ABO incompatibility (18.1%), Rh incompatibility (13.8%), neonatal sepsis (15.6%), and breastfeeding (49.4%). Home delivery correlated with cephalohematoma, meconium aspiration syndrome, and neonatal mortality (p<0.05). Overall mortality due to hyperbilirubinemia was 5.6%, significantly linked to higher bilirubin levels (p=0.025 for total and p=0.014 for direct).
Conclusion: Neonatal hyperbilirubinemia remains a substantial burden in this population, with late presentation, non-facility delivery, prolonged/excessive breastfeeding, and blood-group incompatibilities emerging as the principal determinants of severe bilirubin elevation and mortality.
Keywords:
Neonatal jaundice, Hyperbilirubinemia, Risk Factor of Jaundice, Bilirubin level, Swat, PakistanDOI
https://doi.org/10.37022/wjcmpr.v8i2.409References
1. Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in Neonates : Types , Causes , Clinical Examinations , Preventive Measures and Treatments : A Narrative Review Article. 2016;45(5):558–68.
2. Geest BAM Van Der, Mol MJS De, Barendse ISA, Graaf JP De, Bertens LCM, Poley MJ, et al. Assessment , management , and incidence of neonatal jaundice in healthy neonates cared for in primary care : a prospective cohort study. 2022;1–12.
3. Nemri A Al, Neonatologist C. Neonatal Jaundice Hyperbilirubinemia. 2020;
4. Vítek L, Tiribelli C. Expert Opinion Bilirubin : The yellow hormone ? J Hepatol [Internet]. 2021;75(6):1485–90. Available from: https://doi.org/10.1016/j.jhep.2021.06.010
5. Maqsood A, Taqi S, Zaidi H, Saba A, Shujaat W, Fatima B, et al. R o l e o f S u b c u t a n e o u s B i l i r u b i n o m e t r e i n t h e E v a l u a t i o n o f B i l i r u b i n L e v e l i n N e o n a t a l J a u n d i c e. 2023;73(4):1016–9.
6. Mbah MI, Emmanuel H, Samari MS. Incidence and Risk Factors to Neonatal Jaundice in Jalingo , Taraba State. 2022;152–63.
7. Health I. Epidemiology of neonatal jaundice at Punakha District Hospital , Punakha , Bhutan. 2022;1–7.
8. Fanello C, Lee SJ, Bancone G, Kayembe D, Ndjowo P, Badjanga B, et al. Prevalence and Risk Factors of Neonatal Hyperbilirubinemia in a Semi-Rural Area of the Democratic Republic of Congo : A Cohort Study. 2023;109(4):965–74.
9. Yu Y, Choi J, Lee MH, Kim K, Ryu HM, Han HW. Maternal disease factors associated with neonatal jaundice : a case – control study. BMC Pregnancy Childbirth [Internet]. 2022; Available from: https://doi.org/10.1186/s12884-022-04566-6
10. Qumer M, Fatima T, Albert A, Riaz S. Knowledge , Attitude and Practices of Women Towards the Neonatal Jaundice in Pakistan. 2022;(June).
11. Naeem H, Ullah K, Ochani S, Naeem K. The need for neonatal jaundice screening awareness in the Pakistani population : short communication. :4187–9.
12. Tikmani SS, Warraich HJ, Abbasi F, Rizvi A, Darmstadt GL. Incidence of neonatal hyperbilirubinemia : a population-based prospective study in Pakistan. 2010;15(5):502–7.
13. Sgro M, Campbell D, Shah V. R esearch. 2006;587–90.
14. Scrafford CG, Mullany LC, Katz J, Khatry SK, Leclerq SC, Gary L, et al. Incidence of and risk factors for neonatal jaundice among newborns in southern Nepal. 2013;18(11):1317–28.
15. Isa HM, Albuainain NY, Bunajem FY, Masood AS, Bucheery YA. Neonatal and Maternal Risk Factors for Indirect Hyperbilirubinemia : A Cross-Sectional Study from Bahrain. 2022;2022.
16. Alsaedi SA. Transcutaneous bilirubin measurement in healthy Saudi term newborns. 2016;37(2):142–6.
17. Kasemy ZA, Bahbah WA, Hefnawy SM El, Alkalash SH. Prevalence of and mothers ’ knowledge , attitude and practice towards glucose-6- phosphate dehydrogenase deficiency among neonates with jaundice : a cross- sectional study. 2020;
18. Tahir A, Abid U, Batool I, Zaman N, Ahmad N, Khaleel S, et al. Umbilical Cord Blood Bilirubin and Determination of Neonatal Hyperbilirubinemia. 2023;19(1):20–3.
Published
Abstract Display: 7 How to Cite
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
